
BioNTech and Autolus Therapeutics have announced that they have entered a strategic collaboration intended to further both companies’ autologous CAR …

The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …

The UK is making a £30 million R&D investment into a promising new type of cancer treatment and is to …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

